These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 37017917)

  • 21. Selection and Application of Aptamers and Intramers.
    Avci-Adali M
    Adv Exp Med Biol; 2016; 917():241-58. PubMed ID: 27236559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progress and Challenges in Developing Aptamer-Functionalized Targeted Drug Delivery Systems.
    Jiang F; Liu B; Lu J; Li F; Li D; Liang C; Dang L; Liu J; He B; Badshah SA; Lu C; He X; Guo B; Zhang XB; Tan W; Lu A; Zhang G
    Int J Mol Sci; 2015 Oct; 16(10):23784-822. PubMed ID: 26473828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decellularized orthopaedic tissue-engineered grafts: biomaterial scaffolds synthesised by therapeutic cells.
    Nie X; Wang DA
    Biomater Sci; 2018 Oct; 6(11):2798-2811. PubMed ID: 30229775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Future Prospects for Scaffolding Methods and Biomaterials in Skin Tissue Engineering: A Review.
    Chaudhari AA; Vig K; Baganizi DR; Sahu R; Dixit S; Dennis V; Singh SR; Pillai SR
    Int J Mol Sci; 2016 Nov; 17(12):. PubMed ID: 27898014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor-targeted drug delivery with aptamers.
    Zhang Y; Hong H; Cai W
    Curr Med Chem; 2011; 18(27):4185-94. PubMed ID: 21838687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic applications of synthetic nucleic acid aptamers.
    Poolsup S; Kim CY
    Curr Opin Biotechnol; 2017 Dec; 48():180-186. PubMed ID: 28582756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanoparticle-aptamer bioconjugates for cancer targeting.
    Farokhzad OC; Karp JM; Langer R
    Expert Opin Drug Deliv; 2006 May; 3(3):311-24. PubMed ID: 16640493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanotechnology and aptamers: applications in drug delivery.
    Levy-Nissenbaum E; Radovic-Moreno AF; Wang AZ; Langer R; Farokhzad OC
    Trends Biotechnol; 2008 Aug; 26(8):442-9. PubMed ID: 18571753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aptamer-based molecular recognition for biosensor development.
    Zhou J; Battig MR; Wang Y
    Anal Bioanal Chem; 2010 Nov; 398(6):2471-80. PubMed ID: 20644915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Advances in the study of aptamer-based drug for targeting therapy].
    Dou XQ; Fu J; Song HF
    Yao Xue Xue Bao; 2016 Jul; 51(7):1068-76. PubMed ID: 29897179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absolute quantification of cell-bound DNA aptamers during SELEX.
    Avci-Adali M; Wilhelm N; Perle N; Stoll H; Schlensak C; Wendel HP
    Nucleic Acid Ther; 2013 Apr; 23(2):125-30. PubMed ID: 23405949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving aptamer performance with nucleic acid mimics: de novo and post-SELEX approaches.
    Oliveira R; Pinho E; Sousa AL; DeStefano JJ; Azevedo NF; Almeida C
    Trends Biotechnol; 2022 May; 40(5):549-563. PubMed ID: 34756455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aptamer modules as sensors and detectors.
    Famulok M; Mayer G
    Acc Chem Res; 2011 Dec; 44(12):1349-58. PubMed ID: 21819040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aptamers as targeted therapeutics: current potential and challenges.
    Zhou J; Rossi J
    Nat Rev Drug Discov; 2017 Mar; 16(3):181-202. PubMed ID: 27807347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Nucleic acid aptamer-based traditional Chinese medicine application:therapy,targeting and diagnosis].
    Kui HQ; Li CX; Song YR; Liu GZ; Liu R; Chen YW; Liu YY
    Zhongguo Zhong Yao Za Zhi; 2021 Jun; 46(12):3165-3170. PubMed ID: 34467709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aptamers: multifunctional molecules for biomedical research.
    Banerjee J; Nilsen-Hamilton M
    J Mol Med (Berl); 2013 Dec; 91(12):1333-42. PubMed ID: 24045702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploiting the bioengineering versatility of lactobionic acid in targeted nanosystems and biomaterials.
    Alonso S
    J Control Release; 2018 Oct; 287():216-234. PubMed ID: 30149049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using Exonucleases for Aptamer Characterization, Engineering, and Sensing.
    Alkhamis O; Canoura J; Ly PT; Xiao Y
    Acc Chem Res; 2023 Jul; 56(13):1731-1743. PubMed ID: 37314701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell adhesion on an artificial extracellular matrix using aptamer-functionalized PEG hydrogels.
    Chen N; Zhang Z; Soontornworajit B; Zhou J; Wang Y
    Biomaterials; 2012 Feb; 33(5):1353-62. PubMed ID: 22079002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aptamers as Versatile Ligands for Biomedical and Pharmaceutical Applications.
    Guan B; Zhang X
    Int J Nanomedicine; 2020; 15():1059-1071. PubMed ID: 32110008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.